Archive
A cannabis lease should allocate the risk that the premises cannot be licensed or opened as planned. Build zoning, owner consent, regulator cooperation, construction, inspection, transfer, and default rules into the lease before rent and buildout obligations harden.
A physician can agree on an annual salary and still have a compensation dispute because the contract never defines what happens around the salary.
An MSO should not run two unrelated compliance programs, and it cannot run one identical program in two states. The workable model is a controlled enterprise baseline with jurisdiction-specific overlays, owners, evidence, and change gates.
Missouri codified a product-specific intoxicating-cannabinoid regime at RSMo §195.900. The transition requires SKU classification, channel decisions, age controls, branding review, and coordination with the licensed marijuana system.
Cannabis site diligence should identify zoning, distance, local-approval, owner-consent, facility, and regulator requirements before the operator makes a major nonrefundable commitment. A state license and a signed lease do not make a parcel legally usable.
Illinois cannabis law does not require employers to ignore workplace impairment, and it does not authorize every adverse action based on off-duty use. A defensible program connects written policy, the statutory impairment process, testing design, and workforce privacy controls.
Cannabis brands need a protection plan that separates federal registrability from state-law rights, common-law use, contracts, domains, packaging, and genuinely lawful goods or services.
How the April 2026 Schedule III rule for state medical marijuana, the two-step federal hemp redefinition, the Illinois Hemp Act and Missouri’s House Bill 2641 fit together for operators licensed in Illinois or Missouri, with the 2026 dates to calendar.
Illinois social equity and Missouri microbusiness licenses turn on who owns and who controls the business. How the eligibility definitions, principal-officer and owner rules, transfer approvals, and the Illinois five-year repayment rule shape investor rights and financing documents.
Illinois dispensaries can accumulate identity, purchase, loyalty, marketing, biometric, payment, and medical-program information across several vendors. The compliance problem starts with what the Cannabis Regulation and Tax Act permits the dispensary to collect, retain, use, share, and disclose.